| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-08 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Sale | -8,147 | -37.62%13,510 | $200.00 | $1,629,400 | View SEC filing | |
| 2026-06-02 | Davis J. E. CEO and President | Sale | -10,000 | -7.02%132,423 | $194.14 | $1,941,400 | View SEC filing | |
| 2026-03-06 | Doherty Catherine T. EVP, Regional Businesses | Sale | -5,558 | -7.65%67,122 | $206.21 | $1,146,115 | View SEC filing | |
| 2026-03-06 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | -3,878 | -9.36%37,557 | $206.21 | $799,682 | View SEC filing | |
| 2026-03-06 | Plewman Patrick SVP for Diagnostic Services | Sale | -2,855 | -15.81%15,198 | $206.21 | $588,730 | View SEC filing | |
| 2026-03-06 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Sale | -2,628 | -16.35%13,441 | $204.86 | $538,372 | View SEC filing | |
| 2026-03-04 | Doherty Catherine T. EVP, Regional Businesses | Sale | -632 | -0.93%67,122 | $207.73 | $131,285 | View SEC filing | |
| 2026-03-04 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | -526 | -1.38%37,557 | $207.73 | $109,266 | View SEC filing | |
| 2026-03-04 | Davis J. E. CEO and President | Sale | -10,000 | -7.86%117,185 | $212.52 | $2,125,200 | View SEC filing | |
| 2026-03-04 | Plewman Patrick SVP for Diagnostic Services | Sale | -410 | -2.63%15,198 | $207.73 | $85,169 | View SEC filing | |
| 2026-02-20 | Doherty Catherine T. EVP, Regional Businesses | Sale | -1,433 | -2.05%68,402 | $204.83 | $293,521 | View SEC filing | |
| 2026-02-20 | Plewman Patrick SVP for Diagnostic Services | Sale | -958 | -5.70%15,838 | $204.83 | $196,227 | View SEC filing | |
| 2026-02-20 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | -1,111 | -2.81%38,371 | $204.83 | $227,566 | View SEC filing | |
| 2026-02-17 | Doherty Catherine T. EVP, Regional Businesses | Sale | -26,165 | -27.77%68,068 | $206.15 | $5,393,815 | View SEC filing | |
| 2026-02-12 | Plewman Patrick SVP for Diagnostic Services | Sale | -5,662 | -26.91%15,381 | $204.00 | $1,155,048 | View SEC filing | |
| 2025-11-28 | Davis J. E. CEO and President | Sale | -55,093 | -31.38%120,480 | $192.22 | $10,589,760 | View SEC filing | |
| 2025-11-28 | Gregg Vicky B Director | Sale | -1,250 | -6.84%17,037 | $191.76 | $239,700 | View SEC filing | |
| 2025-11-20 | DELANEY MARK E SVP & Chief Commercial Officer | Sale | -7,946 | -51.34%7,530 | $187.35 | $1,488,683 | View SEC filing | |
| 2025-10-24 | PFEIFFER GARY M Director | Sale | -1,482 | -4.79%29,431 | $182.40 | $270,317 | View SEC filing | |
| 2025-09-30 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | -227 | -0.59%38,117 | $188.13 | $42,706 | View SEC filing | |
| 2025-09-25 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | -28,463 | -42.60%38,117 | $187.12 | $5,326,042 | View SEC filing | |
| 2025-08-25 | Plewman Patrick SVP for Diagnostic Services | Sale | -1,975 | -11.45%15,269 | $185.00 | $365,375 | View SEC filing | |
| 2025-08-21 | Plewman Patrick SVP for Diagnostic Services | Sale | -4,532 | -20.81%17,244 | $183.00 | $829,356 | View SEC filing | |
| 2025-08-19 | Plewman Patrick SVP for Diagnostic Services | Sale | -1,975 | -10.28%17,244 | $180.00 | $355,500 | View SEC filing | |
| 2025-08-08 | Plewman Patrick SVP for Diagnostic Services | Sale | -5,535 | -22.33%19,219 | $175.00 | $968,625 | View SEC filing |
1-25 of 431
